Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.4.1 added; Revision: v3.4.0 removed.
    Difference
    0.0%
    Check dated 2026-02-05T17:29:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The update adds UI/metadata changes: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-29T06:54:34.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; this is a minor metadata change and does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:46:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Expanded the Study Details page to include a broader Locations section with numerous new trial sites across the United States, Australia, and other countries.
    Difference
    2%
    Check dated 2025-12-24T14:07:07.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate publications are automatically filled from PubMed, with Revision: v3.3.2 added. The previous text implying that publications come directly from PubMed was removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:48.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A general government funding/status notice was removed from the page. All trial details, eligibility criteria, and links remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-18T07:21:53.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.